These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37299411)

  • 1. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death.
    Huang TY; Yang CK; Chen MY; Yadav VK; Fong IH; Yeh CT; Cherng YG
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib through the PERK-ATF4-Beclin1 Pathway.
    Zhou B; Lu Q; Liu J; Fan L; Wang Y; Wei W; Wang H; Sun G
    Int J Biol Sci; 2019; 15(9):1905-1920. PubMed ID: 31523192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib enhances proteasome inhibitor-mediated cytotoxicity via inhibition of unfolded protein response and keratin phosphorylation.
    Honma Y; Harada M
    Exp Cell Res; 2013 Aug; 319(14):2166-78. PubMed ID: 23727131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pristimerin synergistically sensitizes conditionally reprogrammed patient derived-primary hepatocellular carcinoma cells to sorafenib through endoplasmic reticulum stress and ROS generation by modulating Akt/FoxO1/p27
    Tang Y; Chen J; Li J; Zheng Y; Zhong X; Huang S; Chen B; Peng B; Zou X; Chen X
    Phytomedicine; 2021 Jun; 86():153563. PubMed ID: 33951569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
    Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
    Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16-O-caffeoyl-16-hydroxylhexadecanoic acid, a medicinal plant-derived phenylpropanoid, induces apoptosis in human hepatocarcinoma cells through ROS-dependent endoplasmic reticulum stress.
    Huang RZ; Huang XC; Zhang B; Jia HY; Liao ZX; Wang HS
    Phytomedicine; 2018 Mar; 41():33-44. PubMed ID: 29519317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells.
    Du H; Wu H; Kang Q; Liao M; Qin M; Chen N; Huang H; Huang D; Wang P; Tong G
    Aging (Albany NY); 2023 Nov; 15(21):12251-12263. PubMed ID: 37934581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
    J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro.
    Chang HL; Chen HA; Bamodu OA; Lee KF; Tzeng YM; Lee WH; Tsai JT
    Toxicol In Vitro; 2018 Sep; 51():74-82. PubMed ID: 29698666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
    Chen MY; Hsu CH; Setiawan SA; Tzeng DTW; Ma HP; Ong JR; Chu YC; Hsieh MS; Wu ATH; Tzeng YM; Yeh CT
    Phytomedicine; 2023 Jan; 108():154478. PubMed ID: 36265255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2E1 triggered GRP78/ATF6/CHOP signaling axis inhibit apoptosis and promotes progression of hepatocellular carcinoma.
    Ishteyaque S; Yadav KS; Verma S; Washimkar KR; Mugale MN
    Arch Biochem Biophys; 2023 Sep; 745():109701. PubMed ID: 37499993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyperus amuricus induces G1 arrest and apoptosis through endoplasmic reticulum stress and mitochondrial signaling in human hepatocellular carcinoma Hep3B cells.
    Pham HHT; Seong YA; Ngabire D; Oh CW; Kim GD
    J Ethnopharmacol; 2017 Aug; 208():157-164. PubMed ID: 28684299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress.
    Shi Y; Ma J; Chen KE; Chen B
    Oncol Res; 2022; 30(4):201-210. PubMed ID: 37304412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways.
    Hsu CH; Weng PW; Chen MY; Yeh CT; Setiawan SA; Yadav VK; Wu ATH; Tzeng DTW; Gong JX; Yang Z; Tzeng YM
    Chem Biol Interact; 2023 Jan; 370():110329. PubMed ID: 36565974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy.
    Vandewynckel YP; Laukens D; Bogaerts E; Paridaens A; Van den Bussche A; Verhelst X; Van Steenkiste C; Descamps B; Vanhove C; Libbrecht L; De Rycke R; Lambrecht BN; Geerts A; Janssens S; Van Vlierberghe H
    Hepatol Int; 2015 Jan; 9(1):93-104. PubMed ID: 25598862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1.
    Cao X; Liu L; Yuan Q; Li X; Cui Y; Ren K; Zou C; Chen A; Xu C; Qiu Y; Quan M; Zhang J; Cao J; Chen X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):264. PubMed ID: 31208440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.